Starting or Strengthening a Drug Bulletin - A Practical Manual
(2005; 165 pages) View the PDF document
Table of Contents
View the documentPreface
View the documentHow the manual was produced
View the documentAbout ISDB
View the documentExecutive summary
Open this folder and view contents1. Introduction
Open this folder and view contents2. Rational use of medicines
Open this folder and view contents3. What are drug bulletins?
Open this folder and view contents4. Defining aims, target and type of bulletin
Close this folder5. Planning resources
View the document5.1 The first steps in planning
View the document5.2 Identify what is already available or accessible
View the document5.3 Make a realistic assessment of additional needs
Open this folder and view contents5.4 Human resources: who will do the work?
View the document5.5 Maintaining the motivation of contributors
View the document5.6 Material resources - an office, equipment and references
View the document5.7 Financial resources - the key to sustainability
View the document5.8 Long-term sustainability
View the document5.9 Cost-saving strategies
View the document5.10 Key messages for starting a drug bulletin
View the document5.11 References
Open this folder and view contents6. Planning bulletin production: schedules and timing
Open this folder and view contents7. The editorial process
Open this folder and view contents8. Reviewing a new drug: is it a therapeutic advance?
Open this folder and view contentsAnnexe to Chapter 8: Evaluating harm
Open this folder and view contents9. Design and production
Open this folder and view contents10. Dissemination
Open this folder and view contents11. Organizational and legal issues
Open this folder and view contents12. Evaluating quality and usefulness
Open this folder and view contents13. Partnership and collaboration
Open this folder and view contents14. Keeping records and creating a memory
Open this folder and view contentsAppendix: Electronic sources of information
 

5.5 Maintaining the motivation of contributors

There are three main ways to motivate editors, authors and advisers:

• through adequate acknowledgement of their contributions;
• through remuneration;
• through attention to their values and needs (for example, by providing feedback, explanation, respect, etc.).


Bulletins that can afford it should pay their authors and editors, and sometimes also give some form of honorarium to members of the editorial or advisory board. You can also thank your reviewers in a way that is inexpensive, but still shows that you appreciate their contribution. The most important thing is to handle their comments with care and treat them with respect. They will always appreciate it if you give them some form of feedback on how you handled their comments, although this can be time-consuming. In this way you will be more likely to get their continued support. (See also Chapter 7, Sections 7.3.2 and 7.4.7).

Case study: Drugs Bulletin - Chandigarh, India

Drugs Bulletin is published by the Department of Pharmacology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India. It is a quarterly publication, which has been published since 1976 and is funded by the Institution, a public sector organization.

The bulletin includes only review articles, and the topics are generally selected from current developments and especially those relevant to a developing country. However, topics of international interest, recent advances and pathophysiological aspects are also published. The articles are generally contributed by specialists in their respective fields and the published articles are signed by the authors. No remuneration is offered. However, a complementary copy is provided to each of the authors. This has been our policy ever since the bulletin was started.

Contributed by Promila Pandhi, Drugs Bulletin, India [http://www.pgimer.nic.in].

to previous section
to next section
 
 
The WHO Essential Medicines and Health Products Information Portal was designed and is maintained by Human Info NGO. Last updated: November 5, 2014